France: Stilla Technologies raises €31.3m through convertible bonds and loan

Stilla Technologies, the multiplex digital PCR company, has raised €31.3m (US$35.3m) in the form of €11.3m in convertible bonds and €20m in loan financing. In addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement and Eurazeo, Stilla has attracted investment from leading life science firm…

You must be a HMI Subscriber to view this content.

Subscribe Now »